The “Asia-Pacific Autoimmune Disease Diagnostics Market – Growth, Trends, and Forecast (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering.
The treatment of autoimmune diseases requires diagnosis of the disease at the onset of disease or later. This involves clinical laboratories checking for symptoms and providing the information to physicians for better treatment of the disease. All diagnostic laboratories do not have proper equipment for carrying out immunoassays. In that case, patients will face trouble in getting the tests done and then handing over the result to the physician. To overcome these problems, recently physicians and clinical laboratories started collaborating. Since, a physician knows where proper immunoassays and immunodiagnostics can be carried out, the physician collaborates with that laboratory and suggests the patient to get their tests done from there and the results will directly be sent to the physician. Furthermore, with increasing usage of Electronic Medical Records (EMR), labs have access to real-time test data and metrics extracted from the Laboratory Information System (LIS) and physicians too have access to these records, which increases efficiency in diagnosis, thus boosting autoimmune diagnostics market.
Based on Diagnosis, the market is segmented into Regular Laboratory Tests, Inflammatory Markers, Immunologic Assays, Antibody Tests and Other Tests. The factors responsible for the growth of the market include cost-effectiveness, growth in the biotechnology and pharmaceutical sectors, and high sensitivity and specificity of immunoassays. When compared to conventional tests, immunologic assays have been proven to provide highly accurate results, even with very small samples.
Immunologic reactions are highly specific, as they can take place only in the presence of proper immunologic agents. This high specificity indicates high accuracy in results, enabling high sensitivity in the detection of diseases. It helps in easy detection and eliminates the need for secondary verification, which ultimately saves costs. Hence, owing to these factors, the segment is expected to show better growth in the forecast period.
The market comprises of major market players, and these players are focusing on R&D activities and significant growth strategies. The major players into the Asia-Pacific autoimmune disease diagnostics market are Abbott Laboratories, BioMerieux, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Siemens AG, Trinity Biotech and Thermo Fisher Scientific.
Key Topics Covered:
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter’s Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Disease Type
5.1.1 Systemic Autoimmune Disease
220.127.116.11 Rheumatoid Arthritis
18.104.22.168 Systemic Lupus Erythematosus (SLE)
22.214.171.124 Multiple Sclerosis
126.96.36.199 Other Systemic Autoimmune Diseases
5.1.2 Localized Autoimmune Disease
188.8.131.52 Inflammatory Bowel Disease
184.108.40.206 Type 1 Diabetes
220.127.116.11 Other Localized Autoimmune Diseases
5.2 By Diagnosis
5.2.1 Regular Laboratory Tests
5.2.2 Inflammatory Markers
5.2.3 Immunologic Assays
5.2.4 Antibody Tests
5.2.5 Other Tests
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.3 Bio-Rad Laboratories, Inc.
6.1.4 F. Hoffmann-La Roche Ltd
6.1.5 PerkinElmer, Inc.
6.1.6 Siemens AG
6.1.7 Trinity Biotech
6.1.8 Thermo Fisher Scientific
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/78opkh
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.